The Dan Lewis Foundation for Brain Regeneration Research Announces First Annual DLF Prize to Be Awarded Spring 2023
February 23, 2023 11:00 ET
|
The Dan Lewis Foundation for Brain Regeneration Research (danlewisfoundation.org)
DENVER, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The Dan Lewis Foundation for Brain Regeneration Research (the DLF) happily announces the 2023 DLF Prize. This $15,000 prize will be awarded to an early...
ZyVersa Therapeutics Announces New Publication in Translational Research Showing IC 100 Reduces Inflammasome Activation in Mouse Model for Alzheimer’s Disease Following Traumatic Brain Injury
February 23, 2023 09:20 ET
|
ZyVersa Therapeutics
Data published in Translational Research indicate that pyroptotic release of cytokines and ASC Specks from traumatic brain injury (TBI) induces a heightened inflammasome response in Alzheimer’s...
Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints Global TBI Expert as Advisor
February 21, 2023 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical...
ADM Diagnostics, Inc. Awarded $1.96 Million Grant From the National Institutes of Health
September 27, 2022 09:00 ET
|
ADM Diagnostics Inc
NORTHBROOK, Ill., Sept. 27, 2022 (GLOBE NEWSWIRE) -- ADM Diagnostics, Inc. (ADMdx) has been awarded a two-year $1.96 million Phase II Small Business Innovation Research (SBIR) grant from the...
Study: Improvements in TBI Patients with Persistent Brain Fog
May 16, 2022 07:58 ET
|
Posit Science
SAN FRANCISCO, May 16, 2022 (GLOBE NEWSWIRE) -- A new study has shown that plasticity-based brain training can drive improvements in patients with persistent symptoms from Traumatic Brain Injury...
Worldwide Neurorehabilitation Industry to 2030 - Rising Demand of Telerehabilitation Presents Opportunities
February 17, 2022 05:43 ET
|
Research and Markets
Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "Neurorehabilitation Market by Type, Application, and End-User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
The Worldwide Neurology Patient Monitoring Industry is Expected to Reach $7.4 Billion by 2030
January 26, 2022 07:43 ET
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Neurology Patient Monitoring Market Size, Share & Trends Analysis Report by Application (Trauma, CSF Management, Migraine, Stroke, Hydrocephalus,...
Dr. David Margulies and Dr. Hal C. Lewis Present HEALING and REGENERATING the INJURED BRAIN
January 19, 2022 14:00 ET
|
The Dan Lewis Foundation for Brain Regeneration Research
DENVER, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Talks at Google, a global talk series, recently presented Healing and Regenerating the Injured Brain with Dr. Hal Lewis and Dr. David Margulies. Drs. Lewis...
Neurological Biomarkers Market by Application, by Type, by End-use, by Region and Forecasts to 2028
December 06, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's), By Type (Genomic, Proteomic), By...
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
October 19, 2021 10:03 ET
|
Odyssey Group International
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving...